ADHD in the News 2023-10-12
Narcolepsy Drug Might Be New Treatment Option for ADHD
WEDNESDAY, Oct. 11, 2023 (HealthDay News) -- A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren't getting relief from available treatments, according to a small pilot study.
The A.D.H.D. Drug Shortage Is Causing Real Pain (Opinion)
Edward Krumpotich, a drug policy consultant based in Minnesota, was diagnosed with severe attention deficit hyperactivity disorder at age 15 — but he didn’t get help for it until he was 37. In the interim years he suffered from methamphetamine addiction, which he later realized was driven by attempts to self-medicate his untreated A.D.H.D. He attended more than 30 rehabs before one finally prescribed stimulant medication for him.
ADHD Appears Underdiagnosed in Patients at a Pediatric Headache Clinic
Nearly 1 in 5 children receiving care in a pediatric headache clinic had significant attention difficulties yet lacked a diagnosis of attention-deficit/hyperactivity disorder (ADHD), according to a poster presented at the 52nd Child Neurology Society Annual Meeting in Vancouver, British Columbia, Canada.
DEA extends pandemic telehealth rules for prescribing controlled substances
The Biden administration on Friday extended flexibilities regarding controlled substances to be prescribed via telemedicine. The Drug Enforcement Administration (DEA) said in a notice it would allow providers to continue using telemedicine to prescribe certain controlled substances through the end of 2024.
ADHD drug maker suing DEA over ‘effectively shutting down’ manufacturing
OMAHA, Neb. (WOWT) - During an ongoing national shortage for drugs used to treat attention-deficit-hyperactivity disorder (ADHD), one manufacturer is suing the federal government. A New York-based law firm representing Ascent Pharmaceuticals, Inc. said the Drug Enforcement Administration is keeping its client from manufacturing generic prescriptions to treat ADHD.
3 Reasons Why More Students Are in Special Education
Over the past 40 years, the number of students in special education has doubled due to better identification and less stigma, experts said.
New research finds greater continuity of psychotherapy after shift to telehealth
The rapid transition to virtual care that occurred with the onset of the COVID-19 pandemic resulted in better continuity of psychotherapy visits compared to prior to the pandemic when almost all visits were in-person, according to new research published in Psychiatric Services. In addition, the time between appointments grew shorter after the transition to virtual care. The study results highlight the benefits of continued availability of virtual psychotherapy.
Mixed Findings on Link Between Eczema and Neuropsychiatric Conditions — Increased rates of OCD, anxiety, depression in adults but no clear associations in children
Adults with atopic dermatitis (AD) had a significantly higher prevalence of anxiety, depression, and obsessive-compulsive disorder (OCD) across all severities of the skin disorder, a large retrospective analysis showed. The strongest association was with OCD, which occurred almost 50% more often in patients with AD. Anxiety and depression were more modestly elevated (14% higher) but still significantly different from individuals without AD. Additionally, patients with mild or moderate AD had higher rates of autism, attention deficit-hyperactivity disorder (ADHD), bipolar disorder, and suicide.
Report: Impacts of climate change threaten children’s mental health starting before birth
Climate change poses a particular threat to children and youth, starting before birth and potentially derailing the normal development of physiological systems, cognitive abilities and emotional skills in ways that are sometimes irreversible, according to a report released by the American Psychological Association and ecoAmerica.
Navigating Challenges in Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
In this episode of MEDcast, the expert panelists review newest guidance for prescription of controlled substances using telemedicine, ADHD medication shortage, and approved and emerging stimulants and non-stimulants for the treatment of ADHD.
The ADHD Defense
Sam Bankman-Fried’s quirks helped make him famous. Could they excuse his alleged crimes?